Lexpos News

A new report from the House of Lords Public Services Committee calls for better data sharing and a more proactive Government approach to managing medicines shortages, describing medicines supply as “a national security issue”. Published today (4th February), the report on the Lords Committee’s inquiry into medicines security concludes that the UK is heavily dependent [...]

The post Lords warn medicine shortages now a national security risk appeared first on Community Pharmacy England.

Community Pharmacy England is releasing guidance ahead of a webinar to explain Category H, the new Drug Tariff category, to pharmacy owners. We have published a comprehensive guide to the new Category H, explaining how entry to and price-setting arrangements for Category H will operate, as well as the background to these changes. Briefing: Category H FAQs Category H webpage List of products moving [...]

The post Category H: guidance and support for pharmacy owners appeared first on Community Pharmacy England.

MHRA Class 2 Medicines Recall: Baclofen 10mg/5ml Oral Solution (Syri Limited, T/A SyriMed) Drug alert number: EL(26)A/06 Date issued: 3 February 2026 Syri Limited, T/A SyriMed is recalling batches of product as a precautionary measure due to crystallisation observed over time in the oral solution. DMRC reference number: DMRC-38317957 Company name:Syri Limited, T/A SyriMed Medicine Details [...]

The post MHRA Class 2 Medicines Recall: Baclofen 10mg/5ml Oral Solution (Syri Limited, T/A SyriMed) appeared first on Community Pharmacy England.

This article tackles some of the misconceptions around who can provide Pharmacy First consultations and aims to bust myths to increase understanding of the service. We have previously published a series of articles on myth busting covering a variety of aspects of Pharmacy First. All of these myths can be viewed on our Pharmacy First service [...]

The post Pharmacy First myth busting appeared first on Community Pharmacy England.

MHRA Class 2 Medicines Recall: Carmustine 100mg powder and solvent for concentrate for solution for infusion (Accord Healthcare Ltd) Drug alert number: EL(26)A/05 Date issued: 2 February 2026 Accord Healthcare limited is recalling a single batch due to an out of specification test result. DMRC reference number: DMRC-38091819 Company name: Accord Healthcare Ltd Medicine Details Carmustine [...]

The post MHRA Class 2 Medicines Recall: Carmustine 100mg powder and solvent for concentrate for solution for infusion (Accord Healthcare Ltd) appeared first on Community Pharmacy England.